STARTUP PROFILE

Wave Neuroscience

COUNTRY
USA
FOUNDED
2019
CATEGORY
Neuromodulation
Using EEG-driven brain mapping and personalized neuromodulation protocols to optimize neural activity for cognitive and mental-health outcomes.
Visit website →
Market Notes · Biweekly

Track this company

Funding, launches and regulatory moves across the neurotech startup map.

Subscribed. Check your inbox to confirm.

•
Neurofounders Insights
$   Funding   -
Series B
MODALITY
EEG
FORM FACTOR
Software/app
INTERFACE DEPTH
Software
INDICATION
Psychiatry
TARGET USER
Mixed
REGULATORY STAGE
FDA cleared (510k)
Wave Neuroscience combines EEG-derived brain mapping with personalized neuromodulation, positioning itself as a precision mental-health platform. Its strength is the closed-loop personalization narrative, though the category has many similar “map then stimulate” propositions.
•
Mentioned in Market Notes
MOST RECENT COVERAGE
#
13
Neurotech wants to challenge GLP-1s
27 October – 10 November 2026

Wave Neuroscience and Ampa will bring Wave’s EEG-guided MeRT protocols to the portable Ampa One TMS system. Clinics that license MeRT can now run it on Ampa units they already have.

#
10
Neurotech Has Arrived
15 September – 29 September 2026

Wave Neuroscience partnered with NeuroCare to bring its FDA-cleared MeRT therapy for PTSD onto the NeuroCare Apollo TMS platform. MeRT uses EEG-derived brain data to personalize stimulation within standard TMS frameworks.

Articles featuring
Wave Neuroscience